PMCB insider buying
Every open-market purchase of PharmaCyte Biotech, Inc. (PMCB) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$128.50K
Insiders buying (12m)2
Purchases on record2
Last purchase filedJan 7, 2026
In the last 12 months, 2 insiders of PharmaCyte Biotech, Inc. bought $128.50K of PMCB stock on the open market in 2 reported purchases. The most recent was filed on Jan 7, 2026: Silverman Joshua (CEO and President, Director) bought 100,000 shares at $0.80, worth $80.30K.
Get the next PMCB insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on Telegram